Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
With H1N1 vaccine supplies delayed, attention turns to faster-to-make “virus-like particles.”
As new influenza strains emerge, researchers struggle to speed vaccine development.
A company is preparing human trials of a DNA-based, universal influenza vaccine.
Understanding how viruses evolve could help predict the next outbreak.
Scientists are exploring faster approaches to making vaccines against the H1N1 virus.